| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Michael Feld | CRO;EVP | 2026-08-26 | 165 | $188.49 | $31.10kSell |
| Thomas E. Polen Jr. | CEO;Chair;Pres | 2026-08-13 | 39,126 | $185.00 | $7.24MSell |
| Thomas E. Polen Jr. | CEO;Chair;Pres | 2026-08-13 | 4,152 | $185.00 | $768.12kSell |
| Thomas E. Polen Jr. | CEO;Chair;Pres | 2026-08-13 | 43,278 | $167.25 | $7.24MBuy |
| Roland Goette | Pres;EVP | 2026-08-11 | 2,438 | $180.84 | $440.89kSell |
| Michael Feld | CRO;EVP | 2026-07-27 | 75 | $157.13 | $11.78kSell |
| Michael Feld | EVP Chief Revenue Officer | 2026-06-26 | 75 | $152.80 | $11.46kSell |
| Michael David Garrison | EVP Pres Med.EssntlBioPharm | 2026-06-24 | 1,100 | $145.66 | $160.23kSell |
| Michael David Garrison | EVP Pres Med.EssntlBioPharm | 2026-06-10 | 1,100 | $151.48 | $166.63kSell |
| Thomas E. Polen Jr. | Chairman CEO and President | 2026-06-01 | 2,764 | $146.35 | $404.51kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Curated Wealth Partners LLC | 0.16% | 426,263 | $77.80M | Institution |
| Vincent A. Forlenza | 0.09% | 237,023 | $43.26M | Insider |
| Edward J. Ludwig | 0.07% | 179,124 | $32.69M | Insider |
| William A. Kozy | 0.05% | 131,728 | $24.04M | Insider |
| Thomas E. Polen Jr. | 0.04% | 110,163 | $20.11M | Insider |
| John R. Considine | 0.04% | 96,375 | $17.59M | Insider |
| Henry P. Becton Jr. | 0.04% | 96,225 | $17.56M | Insider |
| Gary M. Cohen | 0.03% | 93,401 | $17.05M | Insider |
| Pb | 0.03% | 77,391 | $14.13M | Institution |
| Timothy M. Ring | 0.02% | 63,806 | $11.65M | Insider |